Mid-term outcomes (up to 5 years) of percutaneous edge-to-edge mitral repair in the real-world according to regurgitation mechanism: A single-center experience.
Nicola BuzzattiPaolo DentiIside Stella ScarfòIlaria GiambuzziDavide SchiaviStefania RuggeriAlessandro CastiglioniMichele De BonisGiovanni La CannaOttavio AlfieriPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
In this single-center real-world experience, 5-year after MitraClip, half of the patients were alive and 3/4 were free from MR, both in FMR and DMR. Symptoms benefit was sustained in both groups. Advanced ventricular remodeling, advanced symptoms, and suboptimal MR reduction were associated with worse results. Refined patient selection, improved efficacy and more data will be all required to improve long-term outcomes.
Keyphrases
- mitral valve
- end stage renal disease
- ejection fraction
- left ventricular
- chronic kidney disease
- aortic stenosis
- newly diagnosed
- heart failure
- magnetic resonance
- aortic valve
- prognostic factors
- electronic health record
- computed tomography
- minimally invasive
- type diabetes
- magnetic resonance imaging
- big data
- sleep quality
- adipose tissue
- transcatheter aortic valve replacement
- left atrial
- ultrasound guided
- coronary artery disease
- atrial fibrillation
- skeletal muscle
- radiofrequency ablation
- glycemic control